Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 11/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | GNAI3 | P08754 | 2/20 | 0.37 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.37 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19334479 | 0.98 | CYP1A2 (0.41) | CYP1A2SIGMAR1EPHX1EPHX2CNR1 | |
| SCHEMBL19983332 | 0.98 | CYP1A2 (0.43) | CYP1A2SIGMAR1EPHX1EPHX2CNR1 | |
| SCHEMBL20033732 | 0.96 | EPHX1 (0.41) | CYP1A2SIGMAR1EPHX1EPHX2GNAI3 | |
| SCHEMBL21166221 | 0.95 | CYP1A2 (0.42) | CYP1A2SIGMAR1EPHX1EPHX2CNR1 | |
| SCHEMBL23084769 | 0.93 | CYP1A2 (0.39) | CYP1A2SIGMAR1EPHX1EPHX2CNR1 | |
| SCHEMBL21166023 | 0.93 | CYP1A2 (0.39) | CYP1A2SIGMAR1EPHX1EPHX2CNR1 | |
| SCHEMBL22752273 | 0.92 | GNAO1 (0.39) | CYP1A2EPHX1CNR1GNAI3GNAO1 | |
| SCHEMBL22778636 | 0.92 | GNAO1 (0.39) | CYP1A2EPHX1CNR1GNAI3GNAO1 | |
| SCHEMBL23084775 | 0.91 | CYP1A2 (0.42) | CYP1A2SIGMAR1EPHX1EPHX2CNR1 | |
| SCHEMBL19334578 | 0.91 | CYP1A2 (0.41) | CYP1A2SIGMAR1EPHX1EPHX2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9938236-B2 | Antiviral agents against HBV infection | DREXEL UNIVERSITY (US) | 2018-04-10 | — | — | US | disclosed |